Product NDC: | 11026-2662 |
Proprietary Name: | Panatuss |
Non Proprietary Name: | Dexbrompheniramine Maleate, Dextromethorphan, Phenylephrine |
Active Ingredient(s): | .5; 5; 2.5 mg/mL; mg/mL; mg/mL & nbsp; Dexbrompheniramine Maleate, Dextromethorphan, Phenylephrine |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11026-2662 |
Labeler Name: | Seyer Pharmatec, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20050901 |
Package NDC: | 11026-2662-2 |
Package Description: | 60 mL in 1 BOTTLE (11026-2662-2) |
NDC Code | 11026-2662-2 |
Proprietary Name | Panatuss |
Package Description | 60 mL in 1 BOTTLE (11026-2662-2) |
Product NDC | 11026-2662 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dexbrompheniramine Maleate, Dextromethorphan, Phenylephrine |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20050901 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Seyer Pharmatec, Inc. |
Substance Name | DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | .5; 5; 2.5 |
Strength Unit | mg/mL; mg/mL; mg/mL |
Pharmaceutical Classes |